| Axiom edition
4
Spring 2010
Focus on Talent management
Implementing patient access schemes in
the UK
How can risk minimisation tools be improved?
An industry perspective
Innovation in patient compliance
Opinion on value demonstration
click
here to view
|
Axiom Digest
2009
A collection of the best articles from
Pope Woodhead's bi-annual newsletter
click
here to view |
Axiom edition
3
Spring 2009
The who, what, when and how of
local EU payer engagement
Registries: Real-world knowledge for competitive
advantage
Has clinical trial disclosure helped the
average patient?
An industry perspective
Focus on commercial innovation and risk
sharing
click
here to view |
Axiom edition
2
Spring/Summer 2008
5 steps to an integrated value
proposition
PW’s ‘digital conversation’
risk
minimisation tool
Success factors for managing
key opinion leaders
Industry and payer perspectives
on cost-effectiveness evaluation
click
here to view |
Axiom edition
1
Autumn 2007
Opinion on Risk Management
Discussion of the five phases to
develop a successful mature
product portfolio
Perspective on the markets in
Poland and Spain
click
here to view |
|
| Risk
rationale
Pharma needs a culture of
proactive pharmacovigilance
and risk minimisation
Pharmaceutical
Marketing Europe
July/August 2007
click
here to view
|
Real
Time Post Marketing Evaluation
of Therapeutic Risk Management
Plans(RMPs)
– A Novel Pharmacoepidemiological Tool?
Pharmacoepidemiology and
Drug Safety 2008
click
here to view
|
